Reports of the demise of the Marine Corps’ legendary AV-8B Harrier II are greatly exaggerated, as evidenced by a U.S. Southern Command video released this week showing Harriers from the amphibious ...

Pfizer has won a $10 billion deal to acquire the fast-rising obesity drug developer Metsera, ending a fierce bidding war with Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer ...

Harvey has closed a new $150 million funding round led by Andreessen Horowitz valuing the San Francisco-based legal AI startup at over $8 billion, according to three sources close to the deal.

TOKYO — President Trump announced Toyota has promised $10 billion in investments toward new manufacturing plants in the US — urging people to “go out and buy a Toyota” in a wide-ranging speech to ...

An MQ-8B Fire Scout unmanned aerial vehicle assigned to the Sea Knights of Helicopter Sea Combat Squadron (HSC-22) conducts flight operations during an underway with the Freedom-class littoral combat ...

Batesville-based Hillenbrand Inc. is set to be acquired by an affiliate of Lone Star Funds, a private investment firm headquartered in Dallas, Texas, the company announced Wednesday. The all-cash deal ...

JPMorgan Chase says it will invest up to $10 billion in companies considered critical to US national security — a sweeping effort by the country’s largest bank to shore up domestic supply chains and ...

Stellantis may be planning to invest $10 billion in the U.S. sector of its business. This is a large move for the international automaker, which has been involved in tariff discussions between ...

The Dust Devils of VX-31 concluded the AV-8B Harrier’s service with a sundown flight at China Lake. The Dust Devils of the U.S. Navy’s Air Test and Evaluation Squadron (VX) 31 concluded the AV-8B ...

The Trump administration is pulling billions of dollars in federal support for 16 states that did not vote for the president in 2024. White House budget director Russ Vought on Wednesday said the ...

Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody. Analysts praised the ...